According to a new report published by Allied Market Research, titled, “Autism Spectrum Disorders Market," The autism spectrum disorders market was valued at $27.3 billion in 2021, and is estimated to reach $43.2 billion by 2031, growing at a CAGR of 4.6% from 2022 to 2031.
Autism spectrum disorder is a neurodevelopment disorder or disability. The exact cause of autism spectrum disease is unknown however, common and rare inherited genetic variations along with non-inherited traits are the common causes of autism spectrum disorder. A patient who suffers from this disorder faces difficulties in social interaction, communication, daily activities, and non-verbal interactions. Patients with autism spectrum disorder show high dependency on repetitive routines and they are very sensitive to environmental changes. However, children show symptoms at an early age as 12 months of age, and symptoms change with their age. This disorder remains a lifetime however early detection helps to improve symptoms. Early diagnosis of this disorder is important during the developmental period of a child.
A surge in cases of autism spectrum disorder, rise in demand for early diagnosis, increase in number of birth rates, a surge in a number of autism spectrum disorder treatment centers, and rise in awareness regarding service of this disorder are the key factors that drive the growth of Autism Spectrum Disorders Market Size.
The increase in the prevalence of autism spectrum disorder and rise in awareness about autism spectrum disorder drives the growth of the Autism Spectrum Disorders Market Size. For instance, in 2021, according to The Autism and Developmental Disabilities Monitoring (ADDM) Network, a program funded by the Centers for Disease Control and Prevention (CDC), an estimate is that about 1 in 44, 8-year-old children have been identified with ASD. In addition, an increase in awareness about autism spectrum disorders and a rise in demand for early diagnosis of various autism spectrum disorders such as autistic disorder, Asperger's syndrome, and pervasive development disorder (PDD) contribute to the growth of the Autism Spectrum Disorders Industry.
Furthermore, the rise in the birth rate, an increase in autism spectrum disorder s diagnosis rate, private & government funding to develop healthcare infrastructure, and a rise in R&D activities for autism spectrum disorder s service boosts the growth of the Autism Spectrum Disorders Industry. For instance, in February 2021, EarliTec Diagnostics, a digital health company, engaged in developing novel diagnostic and therapeutic products for children with autism spectrum disorder s (ASD) and early childhood vulnerabilities, raised $19.5 million in financing to support the early diagnosis and service of autism spectrum disorder (ASD) in children.
Furthermore, Autism Spectrum Disorders Market Trends that drive the growth of the Autism Spectrum Disorders Market Forecast include increase in service approvals, a rise in clinical trials for autism spectrum disorders (ASD), and a new product launched in the market. For instance, in December 2021, Jaguar Gene Therapy, a company accelerating breakthroughs in gene therapy for sizeable patient populations suffering from severe genetic diseases, today announced additional details, including target genes, for its initial preclinical pipeline programs: JAG101 for Type 1 galactosemia; JAG201 for a genetic cause of autism spectrum disorder (ASD) and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and JAG301 for Type 1 diabetes. Furthermore, the rise in healthcare expenditure and improvements in healthcare facilities in developing nations contributes to the growth of the autism spectrum disorder treatment market.
The Autism spectrum disorder treatment market is segmented into service, and disease. location and region.
On the basis of service, the market is divided into behavioral approaches, early intervention, medication, and others. The behavioral approaches segment dominated the Autism Spectrum Disorders Market Share in 2021, and this trend is expected to continue during the forecast period, owing to increasing adoption of behavioral approaches for treatment and an increase in awareness about autism spectrum diseases (ASD) treatment.
By disease, the market is categorized into autistic disorder, Asperger's syndrome, pervasive development disorder (PDD), and others. The autistic disorder segment has the largest Autism Spectrum Disorders Market Share in 2021, and this trend is expected to continue during the forecast period, owing to the increase in the prevalence of the autistic disorder.
By location, the market is classified into hospital, education counselor centers, and others. The education counselor center segment has the largest market share in 2021, and this trend is expected to continue during the forecast period, owing to growth in the prevalence of autism spectrum diseases and a rise in healthcare expenditures.
North America accounted for a majority of the global autism spectrum disorder treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rising in the prevalence of autism spectrum disorder (ASD), well-established healthcare infrastructure, and the presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in incidences of premature childbirth, growing awareness about autism spectrum disorder (ASD), and a high population base.
Key findings of the study
- On the basis of service, the behavioral approaches segment was the highest contributor to the Autism Spectrum Disorders Market Analysis in 2021.
- Based on disease, the autistic disorder segment was the highest contributor to the market in 2021.
- Depending on location, the education counselor center segment was the highest contributor to the market in 2021.
- Region-wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period